Abstract PR03: Cooperative anti-tumor effects of combined inhibition of KRASG12C plus autophagy in preclinical models of KRASG12C-driven lung cancer
Year: 2023
Type: conference-abstract
Source: Molecular Cancer Research
Institutions: University of Utah, Deciphera Pharmaceuticals (United States)
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4367602591
